Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › MEDIASSIST

MEDIASSIST

Medi Assist Healthcare Services Limited
Micro-capHealthcare ↗

What the six lenses say about MEDIASSIST — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹336.5
2026-09-08
VWAP · 1Y anchor
₹415
-18.8% from VWAP
P/E · TTM
28.0×
TTM EPS ₹12.0
52-week range
14%
position low→high
RSI(14)
41
momentum

Own sector index

Healthcare ↗
Neutral

1M

-1.1%

3M

+7.1%

1Y

+14.5%

Breadth >EMA21

55%

How MEDIASSIST’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
6.0
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Micro-cap cohortDRaw
TechnicalD413›

The actual numbers

Price vs VWAP (1y)-18.8%
EMA trend stackDown · 21<50<200
Price vs 200-EMA-13.5%
Price vs 50-EMA-4.2%
RSI(14)41
RS vs Nifty 500 · 3M-8.2%
RS vs sector · 3M-10.8%
52-week range14%
Volume vs 30d avg0.60×
Volume vs 60d avg0.74×
ATR(14) · volatility12.4
Bollinger width · vol contraction0.101
FundamentalD752›

The actual numbers

Return on equity (ROE)10.6%
Operating margin11.3%
Net margin9.8%
Revenue growth · YoY+25.2%
EPS growth · YoY-6.9%
Debt / equity0.06×

Full 8-quarter history in the financials table below.

ValuationD753›

The actual numbers

P/E (TTM)28.0×
TTM EPS₹12.0
52-week range14%
CatalystD950›

The actual numbers

Earnings & momentum47
Capital actions30
Governance114

Every filing in the corporate-announcements panel below.

FlowD858›

The actual numbers

Promoter holding4.6%
Delivery · 30d avg60.2%
Up/down-day asymmetry5.4pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D4 + D8 ) ÷ 2 = 6.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Below threshold
17
Conviction score 17/100 · avg-decile strength 6.0/10
Conviction score17/100›
TechnicalD4›
FundamentalD7›
ValuationD7›
CatalystD9›
FlowD8›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
-0.6pp
+3.5pp
-4.9pp
-6.6pp
+6.8pp
-32.2pp
Nifty 500
Broad-market baseline
-0.7pp
+3.5pp
-5.9pp
-8.2pp
+1.1pp
-37.4pp
Sector
Own-sector index
—
—
-7.3pp
-10.8pp
-7.6pp
-50.7pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

MEDIASSIST daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
336.50-3.85

Relative strength

RS vs baseline · rebased to 100

MEDIASSIST ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
52.70-0.38

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)168181186189191233240242
↳ change QoQ—+7.8%+2.9%+1.6%+1.1%+22.0%+3.0%+0.8%
EBITDA (₹cr)4045444142404548
EBITDA margin24.1%24.8%23.7%21.7%22.0%17.2%18.8%19.8%
PAT (₹cr)19213022238454
↳ change QoQ—+10.9%+42.7%-26.6%+4.5%-65.2%-50.0%+1250.0%
Net margin11.3%11.6%16.1%11.6%12.0%3.4%1.7%22.3%
EPS (₹)2.682.994.203.053.181.130.567.16
D/E————————
YoY growth · Mar '26Revenue +28.0% YoYPAT +145.5% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 1 Sep '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 1 Sep '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 14 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 11 Aug '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 10 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 9 Aug '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 9 Aug '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 8 Aug '26
    LOWgovernance
    Statement of deviation(s) or variation(s) under Reg. 32
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 Aug '26
    LOWgovernance
    Monitoring Agency Report
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 Aug '26
    MEDIUMgovernance
    Appointment
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 Aug '26
    LOWgovernance
    Change in Management
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 8 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 6 Aug '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 4 Aug '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds MEDIASSIST

Mutual funds holding MEDIASSIST (10)

FundWeightAUM ₹crGrade
Kotak Small Cap Reg Gr0.57%18,933
Aditya BSL ELSS Tax Saver Gr0.88%14,660
Aditya BSL ELSS Tax Saver Gr LSP0.88%14,660
ICICI Pru Banking & Fin Svcs Gr0.91%11,229
Canara Robeco ELSS Tax Saver Reg Gr0.74%8,758
ICICI Pru Pharma Healthcare Diag Gr1.27%6,803
Sundaram Small Cap Gr1.14%3,922
Aditya BSL Pharma & Hlthcare Reg Gr0.87%1,074
Bajaj Finserv Bkg and Fincl Svcs Reg Gr0.60%503
Bajaj Finserv Healthcare Reg Gr0.96%377

ETFs holding MEDIASSIST (0)

No tracked ETF holds MEDIASSIST ≥0.5%.

Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare